• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prostate cancer, screening, and prostate-specific antigen: promise or peril?

作者信息

Voss J D

机构信息

Department of Health Care Sciences, George Washington University Medical Center, Washington, DC 20037.

出版信息

J Gen Intern Med. 1994 Aug;9(8):468-74. doi: 10.1007/BF02599070.

DOI:10.1007/BF02599070
PMID:7525903
Abstract
摘要

相似文献

1
Prostate cancer, screening, and prostate-specific antigen: promise or peril?
J Gen Intern Med. 1994 Aug;9(8):468-74. doi: 10.1007/BF02599070.
2
Prostate cancer screening.前列腺癌筛查
Prim Care. 1992 Sep;19(3):637-49.
3
Prostate cancer: enthusiasm for screening.前列腺癌：对筛查的热情。
Med J Aust. 1995 May 15;162(10):540-1.
4
Economic evaluation of a prostate cancer screening program in France: a decision model.法国前列腺癌筛查项目的经济评估：一个决策模型。
Crit Rev Oncol Hematol. 1999 Nov;32(2):167-73. doi: 10.1016/s1040-8428(99)00033-5.
5
Epidemiology and screening for prostate cancer.
Am J Manag Care. 1997 Aug;3(8):1200-5; quiz 1208, 1210.
6
Screening for prostate cancer: recommendations and rationale.前列腺癌筛查：建议与依据。
Am J Nurs. 2003 Mar;103(3):107-10; discussion 111.
7
Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.美国前列腺特异性抗原筛查的成本效益：从欧洲前列腺癌筛查研究中推断。
J Urol. 2011 Mar;185(3):828-32. doi: 10.1016/j.juro.2010.10.079. Epub 2011 Jan 15.
8
Prostate cancer screening: promise and peril--a review.前列腺癌筛查：前景与风险——综述
Cancer Detect Prev. 1999;23(4):316-24. doi: 10.1046/j.1525-1500.1999.99033.x.
9
Prostate cancer. When to offer screening in the primary care setting.前列腺癌。在基层医疗环境中何时提供筛查。
Geriatrics. 2001 Jan;56(1):22-6, 29-31.
10
What is the value of screening for prostate cancer in the US?在美国，前列腺癌筛查的价值是什么？
Nat Clin Pract Oncol. 2005 Nov;2(11):536-7. doi: 10.1038/ncponc0348.

引用本文的文献

1
Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.医生的结果判断和判断偏差是否会导致治疗的不当使用？研究方案。
Implement Sci. 2007 Jun 7;2:18. doi: 10.1186/1748-5908-2-18.
2
Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography.诉讼会影响医疗行为吗？社区放射科医生的医疗事故认知和经验对乳腺钼靶筛查的影响。
Radiology. 2005 Jul;236(1):37-46. doi: 10.1148/radiol.2361040512.
3
International variation in screening mammography interpretations in community-based programs.

本文引用的文献

1
A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.临床局限性前列腺癌替代治疗策略的决策分析。前列腺患者预后研究团队。
JAMA. 1993 May 26;269(20):2650-8.
2
An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.根治性前列腺切除术评估。时间趋势、地理差异及结果。前列腺患者结局研究团队。
JAMA. 1993 May 26;269(20):2633-6. doi: 10.1001/jama.269.20.2633.
3
Risk factors for prostate cancer.前列腺癌的风险因素。
社区项目中乳腺钼靶筛查解读的国际差异。
J Natl Cancer Inst. 2003 Sep 17;95(18):1384-93. doi: 10.1093/jnci/djg048.
4
Towards a philosophy of public health.走向公共卫生哲学。
J Epidemiol Community Health. 1999 Feb;53(2):99-104. doi: 10.1136/jech.53.2.99.
Ann Intern Med. 1993 May 15;118(10):793-803. doi: 10.7326/0003-4819-118-10-199305150-00007.
4
The treatment of localized prostate cancer: what are we doing, what do we know, and what should we be doing? The Prostate Patient Outcome Research Team.
Semin Urol. 1993 Feb;11(1):23-6.
5
Disease-specific survival following routine prostate cancer screening by digital rectal examination.通过直肠指检进行常规前列腺癌筛查后的疾病特异性生存率。
JAMA. 1993 Jan 6;269(1):61-4.
6
Cancer statistics, 1994.1994年癌症统计数据。
CA Cancer J Clin. 1994 Jan-Feb;44(1):7-26. doi: 10.3322/canjclin.44.1.7.
7
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.基于社区的健康男性人群中的血清前列腺特异性抗原。特定年龄参考范围的建立。
JAMA. 1993 Aug 18;270(7):860-4.
8
The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.
J Urol. 1993 Aug;150(2 Pt 1):369-73. doi: 10.1016/s0022-5347(17)35485-x.
9
The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.前列腺癌早期检测的益处与成本。美国癌症协会-国家前列腺癌检测项目的研究人员。
CA Cancer J Clin. 1993 May-Jun;43(3):134-49. doi: 10.3322/canjclin.43.3.134.
10
Prostate cancer: screening, diagnosis, and management.前列腺癌：筛查、诊断与管理
Ann Intern Med. 1993 May 15;118(10):804-18. doi: 10.7326/0003-4819-118-10-199305150-00008.